CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Follow-Up Questions
CapsoVision Inc のCEOは誰ですか？
Mr. Kang-Huai Wang は CapsoVision Inc の President で、2006 から在籍しています。
CV の株価パフォーマンスは？
CV の現在の価格は $4.9 で、最終取引日から 0.11% increased 変動しました。
CapsoVision Inc の主な事業テーマや業界は？
CapsoVision Inc は Health Care 業界、セクターは Health Care に属しています。
